You are not signed in. Sign in.
Authors: J. Geigert, John Geigert
ISBN-13: 9780306480409, ISBN-10: 0306480409
Format: Hardcover
Publisher: Springer-Verlag New York, LLC
Date Published: January 2004
Edition: 1st Edition
This book highlights the challenges facing quality assurance/quality control (QA/QC) in today's biopharmaceutical environment and presents the strategic importance and value generated by QA/QC for their involvement in control of manufacturing. It will put into perspective the need for a graded approach to QA/QC from early clinical trials through market approval.
List of Tables | ||
List of Figures | ||
Ch. 1 | Biopharmaceutical CMC Regulatory Compliance: What is It? | |
Ch. 2 | Are Biopharmaceuticals Really Different? | |
Ch. 3 | Developing the Corporate CMC Regulatory Compliance Strategy | |
Ch. 4 | Can't Ignore cGMPs | |
Ch. 5 | Recombinant Source Material: Master/Working Banks | |
Ch. 6 | Production: Expansion of the Recombinant Organism and Expression of the Biopharmaceutical | |
Ch. 7 | Purification of the Biopharmaceutical | |
Ch. 8 | Biopharmaceutical Drug Product Manufacturing | |
Ch. 9 | Physicochemical/Biological Analysis of the Biopharmaceutical Product | |
Ch. 10 | Managing Process Changes - Demonstrating Product Comparability | |
Ch. 11 | Biopharmaceutical CMC Outsourcing | |
Ch. 12 | Concluding Thoughts on Biopharmaceutical CMC Regulatory Compliance | |
References |